Leukemia Research
Volume 30, Issue 2 , Pages 145-152 , February 2006

Involvement of NF-κB and glutathione in cytotoxic effects of nitric oxide and taxol on human leukemia cells

  • Maria Cláudia Santos-Silva

      Affiliations

    • Department of Clinical Analysis, Center of Health Sciences, Center of Biological Sciences, Universidade Federal de Santa Catarina, Florianópolis, SC 88049-900, Brazil
    • Corresponding Author InformationCorresponding author. Fax: +55 48 3319542.
    • ,
  • Marta Sampaio de Freitas

      Affiliations

    • Department of Pharmacology, Institute of Biology, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ 20551-030, Brazil
    • ,
  • Jamil Assreuy

      Affiliations

    • Department of Pharmacology, Center of Biological Sciences, Universidade Federal de Santa Catarina, Florianópolis, SC 88049-900, Brazil

Received 13 October 2004 ,Accepted 13 June 2005.

References 

  1. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Ann Rev Biochem. 1994;63:175–195
  2. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Ver. 1991;43:109–142
  3. Ignarro LJ, Cirino G, Casini A, Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol. 1999;34:879–886
  4. Ignarro LJ, Byrns RE, Wood KS. Endothelium-dependent modulation of cGMP levels and intrinsic smooth muscle tone in isolated bovine intrapulmonary artery and vein. Circ Res. 1987;60:82–92
  5. Mendelsohn ME, O’Neill S, George D, Loscalzo J. Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem. 1990;265:19028–19034
  6. Hirayama A, Noronha-Dutra AA, Gordge MP, Neild GH, Hothersall JS. S-Nitrosothiols are stored by platelets and released during platelet-neutrophil interactions. Nitric Oxide. 1999;3:95–104
  7. Mohr S, Zech B, Lapetina EG, Brune B. Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Biochem Biophys Res Commun. 1997;238:387–391
  8. Lander HM, Schajpal P, Levine DM, Novogrodsky A. Activation of human peripherical blood mononuclear cells by nitric oxide-generating compounds. J Immunol. 1993;150:1509–1516
  9. Rahman I, MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med. 2000;28:1405–1420
  10. Wang W, Ballatori N. Endogenous glutathione conjugates: occurrence and biological functions. Pharmacol Rev. 1998;50:335–353
  11. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla EB, Valentine JS, et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science. 1993;262:1274–1277
  12. Ghibelli L, Fanelli C, Rotilio G, Lafavia E, Coppola S, Colussi C, et al. Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J. 1998;12:479–486
  13. Singh SP, Wishnok JS, Keshive M, Deen WM, Tannenbaum SR. The chemistry of the S-nitrosoglutathione/glutathione system. Proc Natl Acad Sci USA. 1996;93:14428–14433
  14. Asahi M, Fujii J, Suzuki K, Seo HG, Kuzuya T, Hori M, et al. Inactivation of glutathione peroxidase by nitric oxide. Implication for cytotoxicity. J Biol Chem. 1995;270:21035–21039
  15. Clark AG, Debnam P. Inhibition of glutathione S-transferases from rat liver by S-nitroso-l-glutathione. Biochem Pharmacol. 1988;37:3199–3201
  16. Han J, Stamler JS, Li H, Giffith OW. Inhibition of γ-glutamylcysteine syntethase by S-nitrosylation. In:  Stamler JS,  Gross S,  Moncada S,  Higgs A editor. The Biology of Nitric oxide. London: Portland Press; 1995;p. 114
  17. Becker K, Gui M, Schirmer RH. Inhibition of human glutathione reductase by S-nitrosoglutathione. Eur J Biochem. 1995;234:472–478
  18. Liebmann JE, Hahn SM, Cook JÁ, Lipschultz C, Mitchell JB, Kaufman DC. Glutathione depletion by l-buthionine sulfoximine antagonizes taxol cytotoxicity. Cancer Res. 1993;53:2066–2070
  19. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature. 1979;22:665–667
  20. Kolb JP. Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia. Leukemia. 2000;14:1685–1694
  21. Santos–Silva MC, Freitas MS, Assreuy J. Killing of lymphoblastic leukemia cells by nitric oxide and taxol: involvement of NF-κB. Cancer Lett. 2001;173:53–61
  22. Gosh S, May M, J Koop EB. NF-κB and Rel proteins: evolutionarily conserved mediators of immune response. Annu Rev Immunol. 1998;16:225–260
  23. Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene. 1999;18:6910–6924
  24. Thanos D, Maniatis T. NF-κB: a lesson in family values. Cell. 1995;80:529–532
  25. Baeuerle PA, Baltimore D. NF-κB: ten years after. Cell. 1996;87:13–20
  26. Pahl HL. Activation e targets genes of Rel/NF-κB transcriptions factors. Oncogene. 1999;18:6853–6866
  27. Rayet B, Gélinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene. 1999;18:6938–6947
  28. Griffith OW. Biologic and pharmacologic regulation of mammalian glutathione syntesis. Free Radic Biol Med. 1999;27:922–935
  29. Field L, Dilts RV, Ravichandran R, Lenhert PG, Carnahan GE. An unusually stable thionitrite from N-acetyl-d,l-penicillamine; X-ray crystal and molecular structure of 2-(acetylamino)-2-carboxy-1,1-dimethylethyl thionitrite. J Chem Soc Commun. 1978;249–250
  30. Van De Loosdrecht AA, Nennie E, Ossenkoppele GJ, Beelen RHJ, Langenhuijse MMAC. Cell mediated cytotoxicity against U937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. J Immunol Methods. 1991;141:15–22
  31. Tietze F. Enzymatic method for quantitative determinationn of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969;27:502–522
  32. De Freitas MS, Spohr TCLS, Benedito AB, Caetano MS, Margulis B, Lopes UG, et al. Neurite outgrowth is impaired on HSP70-positive astrocytes through a mechanism that requires NF-κB activation. Brain Res. 2002;27:359–370
  33. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;5:1475–1489
  34. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem. 1976;72:248–254
  35. Richman PG, Meister A. Regulation of γ-glutamil-cysteine syntheatase by nonallosteric feedback inhibition by glutathione. J Biol Chem. 1975;250:1422–1426
  36. Babson JR, Reed DJ. Inactivation of glutathione reductase by 2-cholorethyl nitrosoureaderived isocyanates. Biochem Biophys Res Commun. 1978;83:754–762
  37. Schreck R, Meier B, Mannel DN, Droge W, Baueuerle PA. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med. 1992;175:1181–1194
  38. Rothbarth J, Vahrmeijer AL, Mulder GJ. Modulation of cytostatic efficacy of melphalan by glutathione: mechanisms and efficacy. Chem Biol Interact. 2002;140:93–107
  39. Hamilton D, Fotouhi-Ardakani N, Batist G. The glutathione system in alkylator resistance. Cancer Treat Res. 2002;112:67–87
  40. Berger SJ, Gosky K, Zborowska E, Wilson JKV , Berger NA. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content na Its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer. Cancer Res. 1994;54:4077–4083
  41. Kramer RA, Ahmad GbreeneK S, Vistica DT. Chemosensitization of l-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine. Cancer Res. 1987;47:19593–19597
  42. Medh RD, Gupta V, Awasthi YC. Reversal of melphalan resistance in vivo and in vitro by modulation of glutathione metabolism. Biochem Pharmacol. 1991;42:439–441
  43. Louie KG, Behrens BC, Kinsella TJ, Hamilton TC, Grotzinger KR, McKoy WM, et al. Radiation survival parameters of antineoplastic drug-sensitive and resistant human ovarian cancer cell lines and their modification by buthione sulfoximine. Cancer Res. 1995;45:2110–2115
  44. Rosenberg MD, Colvin OM, Griffith OW, Bigner SH, Elion GB, Horton JK, et al. Establishement of a melphalan-resistant rhabdomyosarcoma xenograft with xross-restance to vincristine and enhanced sensitivity following buthionine sulfoximine-medated glutathione depletion. Cancer Res. 1989;49:6917–6922
  45. Foster MW, McMahon TJ, Stamler JS. S-Nitrosylation in health and disease. Trends Mol Med. 2003;9:160–168
  46. Chatterjee S, Noack H, Possel H, Wolf G. Induction of nitric oxide synthesis lowers intracellular glutathione in microglia of primary glial cultures. Glia. 2000;29:98–101
  47. White AC, Maloney EK, Boustani MR, Hassoun PM, Fanburg BL. Nitric oxide increases cellular glutathione levels in rat lung fibroblasts. Am J Respir Cell Mol Biol. 1995;13:442–448
  48. Byrne CR, Hanson PJ. Induction of heat shock protein 72 by nitric oxide donor in guinea-pig gastric mucosal cells. Eur J Pharmacol. 1998;353:117–122
  49. Berendji DJI , Kolb-Bachofen V, Meyer KL, Kröncke KD. Inflence of nitric oxide on the intracellular reduced glutathione pool: different cellular capacities and strategies to encounter nitric oxide-mediated stress. Free Radic Biol Med. 1999;27:773–780
  50. Wink DA, Nims RW, Darbyshire JF, Christodoulou D, Hanbauer L, Cox GW, et al. Reaction kinetics for nitrosatrion of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of intermediates generated in the NO/O2 reaction. Chem Res Toxicol. 1994;7:519–525
  51. Walker MW, Kinter MT, Roberts RJ, Spitz DR. Nitric oxide-induced cytoxicity: involvement of cellular resistance to oxidative stress and the role glutathione in protetion. Pediatr Res. 1994;37:41–49
  52. Luperchio S, Tamir S, Tannenbaum SR. NO-induced oxidative stress and glutathione metabolism in rodent and human cells. Free Radic Biol Med. 1996;21:513–519
  53. Manna SK, Kuo MT, Aggarwal BB. Overexpression of γ-glutamylcysteine synthetase suppresses tumor necrosis factor induced apopotosis and activation of nuclear transcription factor κB and activator protein 1. Oncogene. 1999;18:4371–4382
  54. Diaz-Cazorla M, Perez-Sala D, Lamas S. Dual effect of nitric oxide donors on cyclooxygenase-2 expression in human mesangial cells. J Am Soc Nephrol. 1999;10:943–952
  55. Marshall HE, Merchant K, Stamler JS. Nitrosation and oxidation in the regulation of gene expression. FASEB J. 2000;14:1889–1900
  56. Kurozumi R, Kojima S. Increase of intracellular glutathione by low-level NO mediated by transcription factor NF-κB in RAW 264.7 cells. Biochim Biophys Acta. 2005;1744:58–67
  57. Zaman GJ, Lankelma J, van Tellingen O, Beijnen J, Dekker H, Paulusma C, et al. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA. 1995;92:7690–7694
  58. Borst P, Evers R, Kool M, Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J Natl Cancer Inst. 2000;92:1295–1302
  59. Ishikawa T, Bao JJ, Yamane Y, Akimaru K, Frindrich K, Wright CD, et al. Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells. J Biol Chem. 1996;271:14981–14988
  60. Kuo MT, Bao J, Furuichi M, Yamane Y, Gomi A, Savaraj N, et al. Frequent coexpression of MRP/GS-X pump and gamma-glutamylcysteine synthetase synthetase mRNA in drug-resistant cells, untreated tumor cells, and normal mouse tissues. Biochem Pharmacol. 1998;55:605–615

PII: S0145-2126(05)00262-6

doi: 10.1016/j.leukres.2005.06.021

Leukemia Research
Volume 30, Issue 2 , Pages 145-152 , February 2006

Article Tools

* Image Usage & Resolution